ANTERIS TECHNOLOGIES GLOBAL CORP. (AVR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AVR

AVR - ANTERIS TECHNOLOGIES GLOBAL CORP.

FNArena Sector : NONE
Year End: December
GICS Industry Group : Consumer Durables & Apparel
Debt/EBITDA: -0.02
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.00

24 Mar
2026

0.000

OPEN

$7.97

0.000

HIGH

$8.00

1,701

LOW

$7.95

TARGET
$13.00 62.5% upside
FNARENA'S MARKET CONSENSUS FORECASTS
AVR: 1
Title FY26
Forecast		 FY27
Forecast
EPS (cps) - 215.3 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202320242025
EPS Basic xxxxxx-395.6
DPS All xxxxxx0.0
Sales/Revenue xxxxxx3.0 M
Book Value Per Share xxxxxx-0.3
Net Operating Cash Flow xxxxxx-120.7 M
Net Profit Margin xxxxxx-4,921.28 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202320242025
Return on Capital Employed xxxxxx-288.46 %
Return on Invested Capital xxxxxx-278.58 %
Return on Assets xxxxxx-174.92 %
Return on Equity xxxxxx-288.46 %
Return on Total Capital xxxxxx-273.37 %
Free Cash Flow ex dividends xxxxxx-123.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202320242025
Short-Term Debt xxxxxx1 M
Long Term Debt xxxxxx3 M
Total Debt xxxxxx3 M
Goodwill - Gross xxxxxx-
Cash & Equivalents - Generic xxxxxx19 M
Price To Book Value xxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202320242025
Capex xxxxxx3.0 M
Capex % of Sales xxxxxx102.14 %
Cost of Goods Sold xxxxxx3 M
Selling, General & Admin. Exp & Other xxxxxx145 M
Research & Development xxxxxx107 M
Investments - Total xxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

09/03/2026

1

Speculative Buy

$13.00

62.50%

Anteris Technologies continues to advance DurAVR toward approval, with Bell Potter highlighting the opening of the US Investigational Device Exemption and a US$320m capital raise.

DurAVR is a transcatheter aortic valve replacement (TAVR) device to treat severe aortic stenosis.

The broker notes the funding round has left incoming investors with 57% ownership, while estimated cash at December 31 reaches around US$313m.

The analyst expects first US patient enrolment in the approval study before the June quarter ends, with around 80 global trial sites involved.

Bell Potter considers US-based Medtronic’s $90m placement a validation of DurAVR technology and potential strategic pathway toward future acquisition interest.

Bell Potter raises its target price to $13.00 from $10.00 and retains a Buy (Speculative) rating.

FORECAST
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -215.32 cents.
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -231.68 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

AVR STOCK CHART

FNArena News on AVR

1
FNArena Corporate Results Monitor – 13-08-2025

Aug 13 2025 - Australia
2
Next Week At A Glance – 29 Jul-2 Aug 2024

Jul 26 2024 - Weekly Reports